Synergy of IL-1 Receptor Antagonist and Anti-CD3 Monoclonal Antibody in Reversal of Diabetes in NOD Mice
Ablamunits V, Opare-Addo L, Henegariu O, Mandrup-Poulsen T, Herold K. Synergy of IL-1 Receptor Antagonist and Anti-CD3 Monoclonal Antibody in Reversal of Diabetes in NOD Mice. Clinical Immunology 2010, 135: s31. DOI: 10.1016/j.clim.2010.03.095.Peer-Reviewed Original Research